Knight Therapeutics Inc.

TSX:GUD.TO

6.14 (CAD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q32012 Q3
Revenue 95.57386.60474.19781.589.90582.59781.65572.28175.8263.80758.27373.3465.79646.06955.19145.23953.2545.83937.2714.033.2042.9563.8883.222.2383.1542.5441.862.481.751.8451.8921.1351.0680.3430.1140.3330.2470.110.0070.2470.0011.5620.463
Cost of Revenue 59.9155.77751.09741.31852.41241.83544.76741.8837.52531.3330.07835.57436.92525.48935.13125.70631.01325.97918.7910.750.3170.6850.5240.6090.3380.8340.4880.3370.4720.2880.4730.2960.5350.2460.0520.0180.2720.08600000.6050.07
Gross Profit 35.66330.82723.140.18237.49340.76236.88830.40138.29532.47728.19537.76628.87120.5820.0619.53322.23719.8618.483.282.8872.2713.3642.6111.92.322.0561.5232.0081.4621.3721.5960.60.8220.2910.0960.0610.1610.110.0070.2470.0010.9580.393
Gross Profit Ratio 0.3730.3560.3110.4930.4170.4940.4520.4210.5050.5090.4840.5150.4390.4470.3630.4320.4180.4330.4960.8140.9010.7680.8650.8110.8490.7360.8080.8190.810.8350.7440.8440.5290.770.8480.8420.1830.65111110.6130.849
Reseach & Development Expenses 5.8064.984.2584.7684.3364.1874.144.223.4122.9833.4963.7932.5852.8183.692.9672.3192.7491.4110.8920.9840.6260.4920.4380.5720.4890.8810.5860.8670.4160.7120.4360.5240.2830.2541.8190.30.3350.2140.6870.1130.0150.2770.284
General & Administrative Expenses 12.09910.5388.10911.089.1199.10610.33610.41610.5668.83211.8638.7639.4517.08211.42110.8358.1718.41812.4264.6493.7873.5982.6021.8331.9372.0951.2542.1472.3292.4682.712.3582.0552.1931.8392.1232.4472.6772.2851.2270.6930.07700
Selling & Marketing Expenses 13.26412.64910.81611.92412.87410.66514.40213.45610.9269.6910.439.999.1847.6138.6577.7639.05110.1144.5291.1251.2880.8470.90710.8920.7891.1310.8341.050.3630.270.0940.15400000000000
SG&A 25.36323.18718.86923.00421.99319.77124.73823.87221.49218.52222.29318.75318.63514.69520.07818.59817.22218.53216.9555.7745.0754.4453.5092.8332.8292.8842.3852.9813.3792.8312.982.4522.2092.1931.8392.1232.4472.6772.2851.2270.6930.0770.3050.046
Other Expenses 0.0420.1690.7821.9070.3111.17117.15612.24311.05511.2880.321-0.286-0.0190.1120.03610.7453.0871.5470.2461.5790.0170.3530.2060.3850.0371.3510.0140.8710.3340.3080.362.0810.3541.0991.5170.3760.5260.4410.0010.3290.1050.00700
Operating Expenses 31.16928.16723.12739.25237.60335.12946.03440.33535.95932.79342.82933.74528.85522.81531.75727.26825.34527.3220.2017.2026.5785.5944.5033.783.8653.833.714.1064.5663.5733.8482.9882.8652.5252.1313.9712.7753.042.5261.940.8320.0990.5450.335
Operating Income 4.4942.66-0.0270.93-0.118.891-6.847-1.6124.9821.074-14.6344.0210.016-2.235-12.353-7.735-3.108-7.46-1.721-3.922-3.691-3.323-1.139-1.169-1.965-1.51-1.654-2.583-2.558-2.111-2.476-1.392-2.265-1.703-1.84-3.875-2.715-2.879-2.417-1.933-0.584-0.0980.3750.062
Operating Income Ratio 0.0470.031-00.011-0.0010.108-0.084-0.0220.0660.017-0.2510.0550-0.049-0.224-0.171-0.058-0.163-0.046-0.973-1.152-1.124-0.293-0.363-0.878-0.479-0.65-1.389-1.031-1.206-1.342-0.736-1.996-1.595-5.364-33.991-8.16-11.638-22.047-280.166-2.362-67.790.240.133
Total Other Income Expenses Net -3.781-9.804-26.1257.5160.239-13.837-16.2882.463-4.346-23.386-0.655-14.35225.4415.32420.06922.51416.302-4.55-5.82-3.81418.3764.169-3.68110.2812.7214.9922.387-0.409-1.9323.7594.0031.3951.585-0.0883.8816.0946.78612.93130.7981.3050.1060.0220.034-0.003
Income Before Tax 0.713-7.144-26.1528.8980.212-4.946-23.1350.8510.636-22.312-14.424-9.88826.5754.42710.85117.14514.606-10.517-3.121-1.67820.8456.7361.12414.0685.5028.778.5163.9671.2087.5087.6267.3785.4443.0258.8156.5167.66714.018130.2260.5070.396-0.0760.410.058
Income Before Tax Ratio 0.007-0.082-0.3520.1090.002-0.06-0.2830.0120.008-0.35-0.248-0.1350.4040.0960.1970.3790.274-0.229-0.084-0.4166.5062.2790.2894.3692.4582.7813.3472.1330.4874.294.1333.94.7962.83225.757.15823.04856.671,188.10973.4651.601-52.5620.2620.126
Income Tax Expense 2.655-2.598-1.826-0.69-1.628-1.009-7.947-0.74-1.88-3.501-6.123-1.302-2.4290.8692.618-0.347-0.906-1.040.0321.2811.8891.5470.9031.1381.4831.8611.3710.3740.7491.461-0.3131.680.9982.5483.2610.239-0.8520.2015.245-0.0560.0050.0410.0090.001
Net Income -1.942-4.546-24.3269.5881.84-3.937-15.1881.5912.516-18.811-8.301-8.58629.0043.5588.23318.09417.449-1.709-6.669-2.95918.9565.1890.22112.934.0196.9097.1453.5930.4596.0477.9395.6984.4460.4775.5546.2778.5213.816124.9810.5620.391-0.0760.40.057
Net Income Ratio -0.02-0.052-0.3280.1180.02-0.048-0.1860.0220.033-0.295-0.142-0.1170.4410.0770.1490.40.328-0.037-0.179-0.7345.9161.7550.0574.0161.7962.1912.8091.9320.1853.4554.3033.0123.9170.44716.19255.06125.61155.8551,140.25881.4371.579-52.5620.2560.123
EPS -0.019-0.045-0.240.090.017-0.035-0.140.0140.022-0.16-0.071-0.070.230.030.0640.140.13-0.013-0.049-0.0220.130.040.0020.0910.0280.050.050.0250.0030.040.0560.040.0390.0050.0540.070.090.151.350.0070.006-0.0090.0070.001
EPS Diluted -0.019-0.045-0.240.090.017-0.035-0.140.0140.022-0.16-0.071-0.070.230.030.0640.140.13-0.013-0.049-0.0210.130.040.0020.090.0280.050.050.0250.0030.040.0550.040.0390.0050.0540.070.090.151.350.0070.006-0.0090.0070.001
EBITDA 17.66315.24111.43119.5915.44521.97413.34713.65618.7614.4556.88418.13210.8136.5830.75913.28311.2716.49943.9482.135-21.903-5.9243.364-10.467-4.336-4.191-3.242-0.6660.124-4.917-5.9250.49-2.5590.3877.4350.9221.4351.557-0.544-0.4110.432-0.050.0340.063
EBITDA Ratio 0.1850.1760.1540.240.1720.2660.1630.1890.2470.2270.1180.2470.1640.1430.0140.2940.2120.1421.1790.53-6.836-2.0040.865-3.251-1.937-1.329-1.274-0.3580.05-2.81-3.2110.259-2.2550.36221.6768.0884.3136.295-4.959-59.581.745-34.6180.0220.137